Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > James Christopher Frankenfield > Profile

James Christopher Frankenfield

Affiliations

Chief Financial Officer at Xilio Therapeutics Inc. (XLO), 2025-01-03

Insider Trading: Sales See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Xilio Therapeutics Inc.	XLO	$0.98	6,954		12,421	2025-01-02	Filing